Article Versions Notes

Wang J-L, Tsai Y-T, Lin C-H, Cidem A, Staniczek T, Chang GR-L, Yen C-C, Chen W, Chong K-Y, Chen C-M. Benefits of Metformin Combined with Pemetrexed-Based Platinum Doublets as a First-Line Therapy for Advanced Lung Adenocarcinoma Patients with Diabetes. Biomolecules. 2021; 11(8):1252. https://doi.org/10.3390/biom11081252

Wang, Jiun-Long, Yi-Ting Tsai, Ching-Heng Lin, Abdulkadir Cidem, Theresa Staniczek, Gary Ro-Lin Chang, Chih-Ching Yen, Wei Chen, Kowit-Yu Chong, and Chuan-Mu Chen. 2021. "Benefits of Metformin Combined with Pemetrexed-Based Platinum Doublets as a First-Line Therapy for Advanced Lung Adenocarcinoma Patients with Diabetes" Biomolecules 11, no. 8: 1252. https://doi.org/10.3390/biom11081252

Wang, J. -L., Tsai, Y. -T., Lin, C. -H., Cidem, A., Staniczek, T., Chang, G. R. -L., Yen, C. -C., Chen, W., Chong, K. -Y., & Chen, C. -M. (2021). Benefits of Metformin Combined with Pemetrexed-Based Platinum Doublets as a First-Line Therapy for Advanced Lung Adenocarcinoma Patients with Diabetes. Biomolecules, 11(8), 1252. https://doi.org/10.3390/biom11081252